Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients (CVCCP)

September 2, 2020 updated by: Beijing Huanxing Cancer Hospital

Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients(CVCCP)

The investigators aim to determine the complications and risk factors related with peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in cancer patients.

Study Overview

Status

Completed

Conditions

Detailed Description

The purpose of this study is to determine the complications and risk factors related with peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in cancer patients.

Study Type

Observational

Enrollment (Actual)

3500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China
        • Beijing Huanxing Cancer Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All adult cancer patients with CVC and PICC placed at BeijingHCH and with written consent for this study

Description

Inclusion Criteria:

  • all adult cancer patients with central venous catheters (CVCs) or peripherally inserted central catheters (PICCs) placed at BeijingHCH.

Exclusion Criteria:

  • without written informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
complications
catheter-related venous thrombosis catheter-related infections

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Catheter-related venous thrombosis and catheter-related infections
Time Frame: 30 days after PICC and CVC line withdrawn
Catheter-related venous thrombosis and catheter-related infections
30 days after PICC and CVC line withdrawn

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Catheter tip position
Time Frame: participants will be followed before PICC and CVC line withdrawn
Catheter tip position
participants will be followed before PICC and CVC line withdrawn

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Beijing Huanxing Cancer Hospital

Investigators

  • Study Chair: Jian DING, MD, Beijing Huanxing Cancer Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

August 1, 2019

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

August 2, 2012

First Submitted That Met QC Criteria

August 6, 2012

First Posted (Estimate)

August 9, 2012

Study Record Updates

Last Update Posted (Actual)

September 3, 2020

Last Update Submitted That Met QC Criteria

September 2, 2020

Last Verified

August 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HCH20120530
  • HCH20120530-008 (Other Identifier: Beijing Huanxing Cancer Hospital)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infections

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe